What Is Epitalon Same as Epithalon? — Nomenclature Explained | Real Peptides

Research published by the St. Petersburg Institute of Bioregulation and Gerontology identified a synthetic tetrapeptide. Ala-Glu-Asp-Gly. That demonstrated telomerase activation in vitro and extended median lifespan in multiple animal models by 20–30%. That compound has been marketed under two primary names: Epitalon and Epithalon. They are identical molecules. The naming variance stems from Russian-to-English transliteration differences. 'Эпиталон' in Cyrillic can be rendered either way depending on whether you follow ISO 9 or BGN/PCGN transliteration standards. The confusion isn't semantic. It creates procurement errors, certificate-of-analysis mismatches, and ordering confusion across global peptide suppliers.

Our team sources peptides internationally and works with research institutions that specify compounds by sequence, not brand name, for exactly this reason. The distinction matters less than most assume. But knowing why the two names exist prevents ordering errors that waste both time and research budgets.

What is the relationship between Epitalon and Epithalon?

Epitalon and Epithalon are the same synthetic tetrapeptide with the amino acid sequence Ala-Glu-Asp-Gly (alanine-glutamic acid-aspartic acid-glycine). The two names result from different transliteration conventions applied to the original Russian name 'Эпиталон.' Both refer to the identical bioactive compound synthesized by Professor Vladimir Khavinson at the St. Petersburg Institute. Not to different formulations, isomers, or derivative peptides.

The Origin of Dual Nomenclature — Why Both Names Exist

The peptide was developed in Russia during the 1980s by Vladimir Khavinson and his research team at the St. Petersburg Institute of Bioregulation and Gerontology. Russian uses the Cyrillic alphabet. The word 'Эпиталон' must be converted to Latin script for international publication and commerce. Two major transliteration systems exist: ISO 9 (used by academic databases and libraries) and BGN/PCGN (used by governments and mapping agencies). Neither system is definitively 'correct'. They prioritise different phonetic goals.

ISO 9 transliteration produces 'Epitalon' because the Cyrillic 'о' maps directly to Latin 'o.' BGN/PCGN transliteration produces 'Epithalon' because it attempts to preserve the aspirated 'th' sound present in some Russian dialects when pronouncing 'т' before certain vowels. Both are valid representations of the same Cyrillic string. The result: scientific literature, peptide suppliers, and regulatory filings use both names interchangeably. Sometimes within the same document.

The practical implication for researchers: when sourcing peptides or cross-referencing studies, search both terms. Certificate-of-analysis documents from European suppliers often list 'Epithalon,' while publications indexed in PubMed Central may use 'Epitalon.' We've guided labs through procurement audits where the mismatch between purchase order terminology and COA labeling triggered internal compliance flags. Not because the compound was different, but because the names didn't match.

Chemical Identity — Same Sequence, Same Mechanism

Epitalon (Epithalon) is a synthetic tetrapeptide bioregulator with the amino acid sequence Ala-Glu-Asp-Gly. Its molecular formula is C14H22N4O9, and its molecular weight is 390.35 g/mol. The compound does not occur naturally in this exact sequence. It was designed as a synthetic analogue of epithalamin, a polypeptide complex extracted from the pineal gland of young calves. Epithalamin contains multiple peptide fragments; Epitalon isolates the specific four-amino-acid sequence hypothesised to drive the telomerase activation and circadian regulation effects observed in early animal studies.

The mechanism centres on telomerase enzyme activation. Telomerase adds repetitive nucleotide sequences (TTAGGG in humans) to the ends of chromosomes. Structures called telomeres. Which shorten with each cell division and eventually trigger replicative senescence when critically shortened. In vitro studies using human fibroblast cell lines demonstrated that Epitalon increased telomerase activity by 33–45% relative to untreated controls, measured via the TRAP assay (telomeric repeat amplification protocol). This effect was dose-dependent and reversible upon peptide withdrawal.

Animal longevity studies conducted by Khavinson's team reported median lifespan extension of 20–30% in rats and mice treated with subcutaneous Epitalon at doses ranging from 0.1 to 1.0 μg/g body weight, administered either daily for 10-day cycles or as a single annual course. The mechanism proposed involves both telomerase upregulation and modulation of melatonin secretion via direct action on pineal epithelial cells. Epitalon administration normalised circadian melatonin rhythms in aged animals whose endogenous production had declined. Whether the longevity effect is driven primarily by telomere maintenance, circadian restoration, or synergistic interaction between the two remains contested.

Our experience with research-grade peptides underscores a consistent pattern: the molecular identity is verified by HPLC-MS (high-performance liquid chromatography-mass spectrometry) regardless of whether the label reads 'Epitalon' or 'Epithalon.' The COA (certificate of analysis) lists the amino acid sequence. Not the transliterated name. As the definitive identifier. If a supplier cannot provide sequence-verified documentation, the name discrepancy is the least of your procurement problems.

Purity, Formulation, and Supplier Variability

The name variance creates no chemical difference, but supplier practices do. Epitalon is commercially available in lyophilised (freeze-dried) powder form, typically at purity levels ranging from 95% to 99.5% as measured by HPLC. Lower-purity preparations contain residual salts (acetate or trifluoroacetate counterions from synthesis), truncated peptide fragments, and trace solvent contaminants. All of which are inert in research applications but reduce the effective concentration of bioactive peptide per milligram.

Lyophilised peptides must be reconstituted with bacteriostatic water or sterile saline before use. The reconstitution solvent, storage temperature, and handling protocol matter more than the name on the vial. Once reconstituted, Epitalon degrades via peptide bond hydrolysis and oxidation. Refrigeration at 2–8°C extends stability to approximately 28 days, while storage at room temperature reduces that window to fewer than 7 days. Unreconstituted lyophilised powder stored at −20°C remains stable for 24–36 months.

We've encountered research teams that assumed 'Epithalon' from one supplier was inherently superior to 'Epitalon' from another based solely on the name. Purity is the only meaningful differentiator. And that's documented on the COA, not the product label. A 95% pure preparation labeled 'Epithalon' is chemically identical to a 95% pure preparation labeled 'Epitalon' if the amino acid sequence matches and the synthesis pathway is the same.

Key Takeaways

• Epitalon and Epithalon are the same tetrapeptide with the amino acid sequence Ala-Glu-Asp-Gly. The naming difference results from two valid Russian-to-English transliteration standards (ISO 9 vs BGN/PCGN).
• The compound was synthesised by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology as a synthetic analogue of epithalamin, a pineal gland extract.
• In vitro studies demonstrated telomerase activation increases of 33–45% in human fibroblast cell lines, and animal studies reported median lifespan extension of 20–30% in rodents treated with subcutaneous Epitalon.
• Purity (95–99.5% via HPLC) and synthesis quality vary by supplier. The transliterated name on the label has no impact on chemical identity, bioactivity, or safety.
• Unreconstituted lyophilised Epitalon stored at −20°C remains stable for 24–36 months; once reconstituted with bacteriostatic water, refrigerate at 2–8°C and use within 28 days.
• When ordering peptides, specify the amino acid sequence (Ala-Glu-Asp-Gly) rather than relying on transliterated names to avoid procurement mismatches or COA discrepancies.

What If: Epitalon / Epithalon Scenarios

What If I Order 'Epitalon' but the COA Lists 'Epithalon' — Is It the Wrong Product?

No. Verify the amino acid sequence on the certificate of analysis instead. If the COA lists Ala-Glu-Asp-Gly and the purity meets your specification (typically ≥95%), the product is correct regardless of which transliterated name appears on the label. The sequence is the definitive identifier. Not the romanised Russian name. We recommend researchers archive COAs indexed by sequence rather than product name to avoid this confusion during internal compliance audits.

What If a Supplier Offers Both 'Epitalon' and 'Epithalon' as Separate Products at Different Prices?

Request the COA for each listing and compare the amino acid sequence, purity, and synthesis method. If both list Ala-Glu-Asp-Gly at comparable purity (within 1–2%), they are the same compound and the price difference reflects marketing positioning rather than formulation variance. If the sequences differ or one lacks HPLC verification, the lower-priced option may be under-specified or impure. Never assume the name difference signals a quality difference without sequence verification.

What If I'm Cross-Referencing Research Studies That Use Both Names — Are the Findings Comparable?

Yes. Studies using 'Epitalon' and 'Epithalon' are referencing the same tetrapeptide and the findings are directly comparable as long as the amino acid sequence, dose, route of administration, and study design are documented. The nomenclature inconsistency does not invalidate cross-study analysis. When conducting systematic reviews or meta-analyses, search both terms to capture the full body of literature. Relying on one term alone will result in incomplete retrieval, particularly from Russian-language publications indexed under the original Cyrillic spelling.

The Straightforward Reality About Epitalon/Epithalon Nomenclature

Here's the honest answer: Epitalon and Epithalon are not two different peptides, competing formulations, or distinct generations of the same compound. They are the same molecule spelled two different ways because the original Russian name had to be converted into Latin script and no single transliteration standard governs global peptide commerce. The confusion is artificial. Driven by inconsistent supplier labeling and the absence of a unified international nomenclature system for research peptides.

The mechanism, bioactivity, molecular weight, and amino acid sequence are identical. If a supplier claims one version is superior, more bioavailable, or 'pharmaceutical-grade' compared to the other based solely on the name, that claim has no scientific basis. Purity, synthesis method, and handling protocol determine quality. Not whether the label uses an 'o' or an 'a' in the third syllable. We mean this sincerely: order by sequence, verify with a COA, and ignore marketing language that frames the two names as meaningful product differentiation.

Sourcing Considerations and Quality Verification

When procuring Epitalon (or Epithalon. The distinction no longer matters), the sequence verification process is non-negotiable. Request a certificate of analysis that includes HPLC chromatogram data, mass spectrometry confirmation of molecular weight (390.35 g/mol ± 0.5), and amino acid sequencing results. The COA should list each residue position: position 1 = alanine, position 2 = glutamic acid, position 3 = aspartic acid, position 4 = glycine. If any position is ambiguous, the peptide is either impure or incorrectly synthesised.

Peptide synthesis quality depends on the coupling efficiency at each step. Solid-phase peptide synthesis (SPPS). The standard method for short peptides. Can produce truncated sequences if coupling reactions are incomplete. A 95% pure preparation may contain 5% des-Ala or des-Gly fragments that are biologically inactive but indistinguishable by appearance. HPLC separates these fragments and quantifies the percentage of full-length peptide. The only metric that matters for research applications.

Storage and handling determine whether the peptide you receive matches the peptide you use six months later. Lyophilised powder should arrive in opaque vials with desiccant packets and should be stored at −20°C immediately upon receipt. Repeated freeze-thaw cycles degrade peptide bonds. Aliquot the powder into single-use portions before reconstitution to avoid this. Once mixed with bacteriostatic water, the solution is stable for 28 days at 2–8°C. After that, hydrolysis and microbial contamination become significant risks even in the presence of bacteriostatic agents.

Researchers working with Thymalin, Cerebrolysin, or Dihexa apply the same sequence-verification and cold-chain storage protocols. The principles are universal: peptides are fragile molecules that degrade predictably under specific conditions, and no amount of brand differentiation or proprietary labeling changes the underlying chemistry. Our commitment to precision synthesis and third-party verification extends across our entire peptide catalog. You can explore additional research-grade compounds through our full peptide collection.

The naming confusion surrounding Epitalon and Epithalon is a transliteration artifact. Not a scientific or regulatory distinction. The peptide's identity is defined by its amino acid sequence (Ala-Glu-Asp-Gly), its mechanism (telomerase activation and circadian modulation), and its documented effects in controlled studies. Everything else. Including which romanisation convention a supplier chooses. Is noise. Specify the sequence, verify the COA, store it correctly, and the name on the vial becomes irrelevant.